article thumbnail

Scandinavia: insight into opportunities for drug discovery

Drug Discovery World

Though not without its challenges, the life sciences industry in Scandinavia is well represented and acts as a serious contender for R&D output. More so, the Karolinska Institute is ranked at number seven in the world for the subjects of life sciences and medicine. We have 3,000 companies in the life sciences sector.

article thumbnail

Combining the Powers of Single Cell Sequencing and AI in Understanding Disease Biology and Drug Development

XTalks

In recent webinars by Genuity Science, formerly known as WuXi NextCODE, experts from the biotech and pharma industries spoke about leveraging the power of single cell RNA sequencing platforms and solutions in conjunction with machine learning technologies such as AI in cell biology and disease research.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

World Glaucoma Week 2024: New Advances in Glaucoma Care

XTalks

Related: Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments — Featuring Pierre Simon, VP Marketing, Sight Sciences – Xtalks Life Science Podcast Ep. Secondly, other funded research is exploring differential gene expression regulated by DNA methylation.

article thumbnail

Synthetic biology: Innovating in drug discovery

Drug Discovery World

Evonetix will use the funding to brings its semiconductor chips to commercial scale and extend gene assembly capabilities for its binary assembly technology to deliver accurate, gene-length DNA in a benchtop instrument. Scientists use human stem cells to create miniature 2D or 3D living systems of tissues and organs.

Drugs 52
article thumbnail

Artificial intelligence could be new blueprint for precision drug discovery

The Pharma Data

online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval. HUMANOID Center of Research Excellence?(CoRE),

Drugs 52
article thumbnail

Otto Bayer Award goes to Prof. Ruth Ley PhD

The Pharma Data

The researcher at the Max Planck Institute for Developmental Biology received the award in a virtual ceremony for her groundbreaking research on the human microbiome – the totality of all microorganisms that naturally colonize a healthy human – which can reach an impressive mass of approximately one kilogram.

article thumbnail

Vtama (tapinarof) Cream Gains FDA Approval for the Treatment of Plaque Psoriasis in Adults

XTalks

This immune-mediated inflammatory disease has been researched thoroughly. Tapinarof treatment in a mouse model of psoriasis resulted in the downregulation of inflammatory cytokine expression in skin tissue, which involved IL17A , IL17F , IL19 , IL22 , IL23A and IL1B gene expression. Clinical Trials of Vtama.